Hilltop Holdings’s Xeris Biopharma Holdings XERS Stock Holding History

Hilltop Holdings’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-43,000	Closed	-$212K	–	566
2020 Q4	$212K	Buy	+43,000	New	+$215K	0.03%	460

Other funds holding XERS

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hilltop Holdings's XERS Position: Q1 2021 in Review

Hilltop Holdings sold out of Xeris Biopharma Holdings (XERS) in Q1 2021, closing a stake of 43,000 shares — an estimated $212K sold.

Hilltop Holdings first reported a position in XERS in Q4 2020 and held it in 1 quarter. The position peaked at $212K in Q4 2020. 103 funds tracked by Wall St. Rank hold XERS as of Q1 2021.

Hilltop Holdings reported no remaining Xeris Biopharma Holdings position as of Q1 2021 after selling out during the quarter.
Hilltop Holdings sold 43,000 Xeris Biopharma Holdings shares in Q1 2021, an estimated $212K.
Hilltop Holdings first reported a position in Xeris Biopharma Holdings in Q4 2020 and held it in 1 quarter.
Hilltop Holdings's Xeris Biopharma Holdings position peaked at $212K in Q4 2020.
103 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2021.

Based on Hilltop Holdings's 13F filing for Q1 2021, filed 17 May 2021.